Efficacy and Safety of IONIS-PKKRx for Preventive Treatment of Chronic Migraine
Status:
Completed
Trial end date:
2019-04-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and changes in the number
of migraine and headache days with repeated subcutaneous administration of IONIS-PKKRx (ISIS
546254) or placebo in subjects with chronic migraine.
Phase:
Phase 2
Details
Lead Sponsor:
Smith, Timothy R., M.D.
Collaborators:
Clinvest Research, LLC Ionis Pharmaceuticals, Inc.